
EXAGEN INC.
Nasdaq · Services-Medical Laboratories
Company Overview
A concise company profile alongside the latest public filing activity.
Exagen Inc. develops and markets blood-based diagnostic tests for autoimmune diseases, including its AVISE line of tests used to help diagnose and monitor conditions such as lupus and rheumatoid arthritis. The company operates a CLIA-certified clinical laboratory in Vista, California, where it processes these tests for rheumatologists and other clinicians.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| ABALLI JOHNPresident and CEO | Sell | $270K | 34,294at $7.87 | Oct 16, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable XGN activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.